185 related articles for article (PubMed ID: 38421446)
21. Craniopharyngiomas: A clinicopathological and molecular study of 52 cases - Experience in the Complejo Hospitalario de Toledo and Hospital Universitario 12 de Octubre (Madrid).
Moreno-Torres B; Campos-Martín Y; Meléndez B; Garcia Martin RM; Vicente A; Rodríguez de Lope Á; Alen JF; Mollejo M; Hernández-Laín A
Clin Neuropathol; 2021; 40(1):26-35. PubMed ID: 33040839
[TBL] [Abstract][Full Text] [Related]
22. Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics.
Robinson LC; Santagata S; Hankinson TC
Neurosurg Focus; 2016 Dec; 41(6):E3. PubMed ID: 27903126
[TBL] [Abstract][Full Text] [Related]
23. The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis.
Preda V; Larkin SJ; Karavitaki N; Ansorge O; Grossman AB
Endocr Pathol; 2015 Mar; 26(1):1-8. PubMed ID: 25355426
[TBL] [Abstract][Full Text] [Related]
24. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
Cao J; Lin JP; Yang LX; Chen K; Huang ZS
Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632
[TBL] [Abstract][Full Text] [Related]
25. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
[TBL] [Abstract][Full Text] [Related]
26. Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features.
Yue Q; Yu Y; Shi Z; Wang Y; Zhu W; Du Z; Yao Z; Chen L; Mao Y
J Neurosurg; 2018 Jul; 129(1):27-34. PubMed ID: 28984520
[TBL] [Abstract][Full Text] [Related]
27. Mutations in exon 3 of the CTNNB1 gene (beta-catenin gene) in cutaneous adnexal tumors.
Kazakov DV; Sima R; Vanecek T; Kutzner H; Palmedo G; Kacerovska D; Grossmann P; Michal M
Am J Dermatopathol; 2009 May; 31(3):248-55. PubMed ID: 19384065
[TBL] [Abstract][Full Text] [Related]
28. CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma.
Apps JR; Stache C; Gonzalez-Meljem JM; Gutteridge A; Chalker J; Jacques TS; Forshew T; Hölsken A; Martinez-Barbera JP
Neuropathol Appl Neurobiol; 2020 Aug; 46(5):510-514. PubMed ID: 32125720
[No Abstract] [Full Text] [Related]
29. Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas.
Hölsken A; Kreutzer J; Hofmann BM; Hans V; Oppel F; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
Brain Pathol; 2009 Jul; 19(3):357-64. PubMed ID: 18540944
[TBL] [Abstract][Full Text] [Related]
30. BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma.
Larkin SJ; Preda V; Karavitaki N; Grossman A; Ansorge O
Acta Neuropathol; 2014; 127(6):927-9. PubMed ID: 24715106
[No Abstract] [Full Text] [Related]
31. Prediction of CTNNB1 Mutation Status in Pediatric Cystic Adamantinomatous Craniopharyngioma by Using Preoperative Magnetic Resonance Imaging Manifestation.
Zhu W; Tang T; Yuan S; Chang B; Li S; Chen M
Clin Neurol Neurosurg; 2021 Jan; 200():106347. PubMed ID: 33160718
[TBL] [Abstract][Full Text] [Related]
32. [Craniopharyngiomas: The Dawn of a New Era with the Elucidation of Driver Genes].
Fujio S; Hanaya R
No Shinkei Geka; 2023 Sep; 51(5):917-928. PubMed ID: 37743344
[TBL] [Abstract][Full Text] [Related]
33. Genomic Alterations in Sporadic Pituitary Tumors.
Bi WL; Larsen AG; Dunn IF
Curr Neurol Neurosci Rep; 2018 Feb; 18(1):4. PubMed ID: 29396598
[TBL] [Abstract][Full Text] [Related]
34. Craniopharyngiomas and odontogenic tumors mimic normal odontogenesis and share genetic mutations, histopathologic features, and molecular pathways activation.
Gomes CC; de Sousa SF; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Mar; 127(3):231-236. PubMed ID: 30598409
[TBL] [Abstract][Full Text] [Related]
35. The molecular pathogenesis of craniopharyngiomas.
Campanini ML; Almeida JP; Martins CS; de Castro M
Arch Endocrinol Metab; 2023 Mar; 67(2):266-275. PubMed ID: 36748936
[TBL] [Abstract][Full Text] [Related]
36. [Etiology, Genetic Features and Clinical Presentations in Craniopharyngiomas].
Horiguchi K
No Shinkei Geka; 2023 Jul; 51(4):607-614. PubMed ID: 37491057
[TBL] [Abstract][Full Text] [Related]
37. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas.
Rickert CH; Paulus W
J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):260-1. PubMed ID: 12531965
[TBL] [Abstract][Full Text] [Related]
38. Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas.
Gomes DC; Jamra SA; Leal LF; Colli LM; Campanini ML; Oliveira RS; Martinelli CE; Elias PC; Moreira AC; Machado HR; Saggioro F; Neder L; Castro M; Antonini SR
Eur J Endocrinol; 2015 May; 172(5):603-8. PubMed ID: 25693592
[TBL] [Abstract][Full Text] [Related]
39. Telomere length and Wnt/β-catenin pathway in adamantinomatous craniopharyngiomas.
Mota JIS; Silva-Júnior RMP; Martins CS; Bueno AC; Wildemberg LE; Antunes XLDS; Ozaki JGO; Coeli-Lacchini FB; Garcia-Peral C; Oliveira AER; Santos AC; Moreira AC; Machado HR; Dos Santos MV; Colli LM; Gadelha MR; Antonini SRR; de Castro M
Eur J Endocrinol; 2022 Jun; 187(2):219-230. PubMed ID: 35584004
[TBL] [Abstract][Full Text] [Related]
40. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
